Anne Arundel Dermatology · 13 hours ago
Pathology Clerk/Data Entry Clerk (Dermatology) Glen Burnie, MD.
US-MD-Glen Burnie
Full-time
Onsite
Entry Level
$20/hr - $23/hr
2+ years expAnne Arundel Dermatology is a well-established healthcare provider specializing in dermatology services. The Pathology Clerk will play a crucial role in coordinating pathology services, maintaining accurate records, and facilitating communication within the healthcare team.
Health Care
Responsibilities
Enter patient demographics into computer
Enter pathologist dictation into computer
Generate and organize pathology reports to be delivered to clients
Document and fax melanoma cases to appropriate locations using proper procedure
File slides and tissue blocks in proper location
Maintain a neat and orderly work area Document and fax melanoma cases to appropriate locations using proper procedure
Enter billing codes and prepare log sheet for billing
Document and mail slide/block requests for consultation
Follow proper protocol to send and receive consult cases
Sort reports and distribute to clients
Display proficiency in retrieving prior/archived pathology reports
Email the Marketing team the log on a monthly basis
Add new locations and physicians to IP
Send out monthly self-pay/discount audit MCBS
Send out monthly missing accession numbers re-released to MCBS
Test interfaces with clients
Fill out supply orders
Back up to the front desk as needed
Other duties assigned as deemed necessary by management
Qualification
Required
High school diploma required
Two or more years of typing at least 40 WPM
Knowledge of and compliance with HIPAA standards
Knowledge of and compliance with OSHA Standard Precautions
Knowledge of and compliance with Chemical Hygiene Practices
Ability to type accurately and efficiently
Preferred
Knowledge of medical terminology a plus
Company
Anne Arundel Dermatology
Anne Arundel Dermatology provides skin care with unique specialties to cover all aspects of medical, surgical and aesthetic dermatology.
1001-5000 employees
Funding
Current Stage
Late StageTotal Funding
unknown2020-10-20Acquired
2015-06-09Private Equity
Leadership Team
Vincent Bradley
Chief Executive Officer
Recent News
2025-07-25
2025-07-22
Company data provided by crunchbase